Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143060 |
| CAS No | NA |
| Mol.F. | C25H33F3N4O7 |
| Mol.Wt. | 558.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143061 |
| CAS No | NA |
| Mol.F. | C20H26F3N3O6 |
| Mol.Wt. | 461.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143062 |
| CAS No | NA |
| Mol.F. | C20H24F3N3O7 |
| Mol.Wt. | 475.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143063 |
| CAS No | NA |
| Mol.F. | C23H32N4O8 |
| Mol.Wt. | 492.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143064 |
| CAS No | NA |
| Mol.F. | C8H12ClN3O2 |
| Mol.Wt. | 217.65 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143065 |
| CAS No | NA |
| Mol.F. | C14H11N5O2 |
| Mol.Wt. | 281.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143066 |
| CAS No | NA |
| Mol.F. | C22H22ClN7O2 |
| Mol.Wt. | 451.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143067 |
| CAS No | NA |
| Mol.F. | C8H10ClN3O2 |
| Mol.Wt. | 215.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143068 |
| CAS No | NA |
| Mol.F. | C14H11N5O |
| Mol.Wt. | 265.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143069 |
| CAS No | NA |
| Mol.F. | C25H28ClN7O2 |
| Mol.Wt. | 494.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143070 |
| CAS No | NA |
| Mol.F. | C41H36ClN7O2 |
| Mol.Wt. | 694.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143071 |
| CAS No | NA |
| Mol.F. | C24H24ClN7O3 |
| Mol.Wt. | 493.95 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143072 |
| CAS No | NA |
| Mol.F. | C22H20ClN7O2 |
| Mol.Wt. | 449.90 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143073 |
| CAS No | NA |
| Mol.F. | C44H43Cl2N13O2 |
| Mol.Wt. | 856.82 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143074 |
| CAS No | NA |
| Mol.F. | C44H43Cl2N13O2 |
| Mol.Wt. | 856.82 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143075 |
| CAS No | NA |
| Mol.F. | C16H13N5O3 |
| Mol.Wt. | 323.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |